I
ron(IV)-hydroxides have been implicated in the catalytic cycles of a number of heme and nonheme enzymes. Bridging or terminal iron(IV)-hydroxides have been proposed for the di-iron centers in the mixed-valent form of ribonucleotide reductase (intermediate X) (1, 2) and the bound radical state of methane monooxygenase (intermediate R) (3) . In heme enzymes, the putative rebound intermediates of cytochrome P450 (4) and nitric oxide synthase (5) are both thought to be iron(IV)-hydroxides, and the ferryl forms of chloroperoxidase (CPO) (6) , horseradish peroxidase (HRP) (7) , cytochrome c peroxidase (8) , myoglobin (9) , and catalase (10) all have recently been reported to be protonated. To date, however, there has been no direct evidence to support the existence of an Fe(IV)OH species in these or any other chemical system.
Reports of iron(IV)-hydroxides are notable. No synthetic or mineral iron-hydroxide above the ferric state has been structurally characterized, and no signal directly associated with the proton of an iron(IV)-hydroxide has ever been reported. Claims of Fe(IV)OH species in heme enzymes have been based on Fe-O bond distances obtained from x-ray structural techniques. Crystal structures of the ferryl forms of HRP, cytochrome c peroxidase, myoglobin, and catalase have yielded Fe-O bond lengths ranging from 1.84 to 1.92 Å (7-10), whereas x-ray absorption measurements on the ferryl form of CPO have provided an Fe-O distance of 1.82 Å (6). X-ray crystallography and x-ray absorption spectroscopy do not allow for the direct observation of protons. In each case, the assignment of an Fe(IV)OH species was based on the observed Fe-O bond length (1.84-1.92 Å), which was deemed too long to be indicative of an authentic Fe(IV)O species (r Fe-O Ϸ 1.65 Å).
The existence of iron(IV)-hydroxides in heme systems has been controversial. The long Fe-O bond lengths reported in crystal structures of the ferryl forms of HRP, cytochrome c peroxidase, and myoglobin are at odds with the much shorter (1.64-1.70 Å) oxo-like bond distances obtained from x-ray absorption spectroscopy (11) (12) (13) . In hopes of clarifying the issue, we recently examined the applicability of Badger's rule to heme iron-oxygen bonds (14). Badger's rule is an empirical formula relating bond distance and vibrational frequency (15) . A theoretical parameterization of Badger's rule was obtained by examining Ͼ30 complexes. Calculations were performed on compounds with different axial-ligands, iron-oxidation, and oxygenprotonation states. The results were impressive. Given the calculated iron-oxygen bond length, Badger's rule predicted the calculated vibrational frequency with an average error of 9 cm Ϫ1 for a 17-molecule training set and an average error of 19 cm
Ϫ1
for a previously unexamined collection of heme and nonheme systems (14 molecules). Our study suggests that Badger's rule is applicable to the iron-oxygen bonds of mononuclear oxo and hydroxo complexes.
A Badger's rule analysis of the available resonance Raman, x-ray absorption, and crystallographic data suggests that the ferryl forms of HRP (pK a Յ 4), cytochrome c peroxidase (pK a Յ 4), and myoglobin (pK a Յ 4) are not iron(IV)-hydroxides (14) . The extended x-ray absorption fine structure and resonance Raman data reported for these systems are in good agreement with Badger's rule (6, (11) (12) (13) (16) (17) (18) (19) , whereas the crystallographically determined bond distances deviate from it substantially (7-9). The long Fe-O bonds that have been reported in the crystal structures of these enzymes appear to be the hallmarks of ferric and ferrous hydroxides (14) .
One complex is a clear outlier in the Fe(IV)OH debate: the ferryl form of the thiolate-ligated heme-enzyme CPO. It is the only ferryl system for which an Fe-O stretching frequency has been unobservable (20) (21) (22) . Several workers have unsuccessfully attempted to locate an 18 O-sensitive stretch in the region where authentic iron(IV)oxo stretching occurs, 655-875 cm Ϫ1 (20, 21) . The assignment of CPO compound II (CPO-II) as an Fe(IV)OH is consistent with their results. X-ray absorption measurements put the Fe-O bond in CPO-II at 1.82 Å, in good agreement with calculations on a thiolate-ligated Fe(IV)OH porphyrin (r Fe-O ϭ 1.81 Å) (6) . Based on the reported Fe-O bond length, we predicted that the Fe-OH stretch in CPO-II would be visible near Badger Ϫ1 . These shifts are in good agreement with the values expected for an Fe-OH harmonic oscillator (23 and 12 cm Ϫ1 , respectively). We also present X-band electron nuclear double resonance (ENDOR) data for cryoreduced CPO-II. Reduction of the EPR-silent Fe(IV)OH center in CPO-II at 77 K results in an EPR-active ferric species with a strongly coupled (13.4 MHz) exchangeable proton. Based on comparisons with alkaline myoglobin, we assign this resonance to the hydroxide proton of cryoreduced CPO-II. Fig. 1 are the oxidation-state marker band ( 4 ) and EPR spectrum of each sample (23) . The EPR spectra and the position of 4 indicate that our CPO-II samples are Ϸ95% pure: The EPR measurements reveal that the samples contain Ͻ5% ferric enzyme, while 4 at 1,377 cm Ϫ1 (2 and 28 cm Ϫ1 higher than in ferric and ferrous CPO, respectively) is indicative of CPO-II. The radical signal near g ϭ 2 is attributed to oxidized ascorbate (24) .
Results and Discussion
The frequency range associated with Fe(IV)-OH stretching in CPO-II is highlighted in Fig. 2 . There, an overlay of the CPO-II spectra as well as their differences can be seen. ) and an x-ray absorption nearedge spectroscopy investigation of alkaline myoglobin (r Fe-OH ϭ 1.84 Å, Badger ϭ 543 cm Ϫ1 ) (14, 28) . It is interesting that the Fe(IV)-OH bond in CPO-II is only slightly (Ϸ0.02 Å) shorter than the Fe(III)-OH bond in alkaline myoglobin. This result, which is consistent with theoretical calculations (14) , reflects the strong electron-donating ability of the axial-thiolate. It is this donating ability that stabilizes the unusual iron(IV)-hydroxide state in CPO-II. ENDOR Spectroscopy. To further support our assignment of the Fe(IV)OH center in CPO-II, we performed X-band continuouswave ENDOR measurements on the cryogenically reduced form of CPO-II (CR-CPO-II). The SA1 Fe(IV)OH center in CPO-II is EPR silent (see EPR spectra in Fig. 1) . Radiolytic reduction ( 4), and EPR spectra of ferric CPO and CPO-II samples (pH 6.5). EPR spectra indicate that CPO-II samples contained Ͻ5% ferric enzyme. The radical signal near g ϭ 2 is attributed to oxidized ascorbate (24) . Arrows highlight movement of the Fe(IV)-OH stretch with isotopic substitution. * , labels the 466-nm line of the argon-ion laser. No movement of the oxidation-state marker band ( 4) was observed during data collection. EPR measurements taken after sample irradiation revealed no detectable change in sample composition. of CPO-II at 77 K results in the formation of an EPR-active ferric hydroxide species (Fig. 3) . The ENDOR spectrum of CR-CPO-II reveals a strongly coupled exchangeable proton resonance (13.4 MHz, 3,100 G) that is similar to the hydroxide resonance (11.4 MHz, 3,100 G) found in alkaline myoglobin. The ENDOR spectra of both species are shown in Fig. 4 . By comparison, we assign the 13.4-MHz resonance of CR-CPO-II to a hydroxide proton. Ϫ1 . X-band continuous-wave ENDOR measurements on the cryoreduced form of CPO-II further support our assignment of an Fe(IV)-OH center in CPO-II. The ENDOR spectrum of CR-CPO-II shows a strongly coupled exchangeable proton (13.4 MHz), which based on comparisons with myoglobin hydroxide, we assign to the hydroxide proton of CR-CPO-II. with 30 mM H 2 O 2 (or H 2 18 O 2 ) in a 2:1 mixture. † The reaction was quenched in liquid ethane (Ϫ180°C) 7 ms after mixing. Reagents were in 100 mM KPhos buffer (pH 6.5). Ethane was decanted and evaporated. Samples were packed into EPR tubes in liquid N 2 . Deuterated CPO-II was prepared as described above, but CPO was exchanged four times with D 2 O buffer, and all reagents were in D 2 O buffer. EPR measurements at 77 K revealed that the CPO-II samples contained Ͻ5% ferric enzyme. Resonance Raman spectra were acquired with a TriVista 555 triple monochromator (900͞900͞2400 gr͞mm; Acton Research, Acton, MA) equipped with a CCD camera (1,340 ϫ 100 pixels; Princeton Instruments, Princeton, NJ). The 454.5-nm line of an argonion laser (I-308; Coherent, Santa Clara, CA) was used for excitation. Power was Ͻ25 mW at the sample. 900͞900͞2,400 gr͞mm gratings provided an instrumental resolution of 1.5 cm Ϫ1 at 454.5 nm (0.51 cm Ϫ1 per CCD pixel). Samples were held in an EPR finger-dewar (77 K) in an Ϸ135°back-scattering arrangement. The 2,326.5-cm Ϫ1 vibration of liquid N 2 was used for calibration. A photoreduction͞degradation study of CPO-II was performed in which the same sample-spot was irradiated continuously for Ͼ4 h (see Fig. 5 , which is published as supporting information on the PNAS web site). No significant change in the sample's spectrum was observed. The CPO-II oxidation-state marker band at 1,377 cm Ϫ1 did not change position over the course of 4 h (23), and no peaks associated with ferric CPO grew in. The CPO-II data presented in Fig. 2 had Ͻ3 h of exposure time. EPR measurements (77 K) taken after laser irradiation showed no detectable change in sample composition. All Raman spectra contained a smoothly varying background, which was removed, but the data were not smoothed or manipulated in any other way. Locations of the difference spectra extrema were obtained by performing a 21-point Savitzky-Golay smoothing. Application of different background subtractions and smoothing procedures resulted in minimal changes (Ͻ2 cm Ϫ1 ) in Fe(IV)-OH stretching frequencies.
Conclusions

Materials and Methods
CPO was obtained from Caldariomyces fumago and purified according to known procedures (29). CPO-II samples
Samples for cryoreduction and ENDOR spectroscopy were prepared by reacting a solution of 37.5 mM ascorbate and 4 mM ferric CPO with 75 mM peracetic acid in a 2:1 mixture. Reactions were quenched into liquid ethane 28 ms after mixing and packed into EPR tubes. Reagents were in 100 mM KPhos buffer (pH 6.5) and 20% (vol͞vol) glycerol. Samples were examined by EPR and resonance Raman spectroscopy before cryoreduction. The EPR measurements revealed that the samples contained Ͻ5% ferric enzyme, whereas resonance Raman measurements indicated they were CPO-II. Samples were ␥-irradiated ( 60 Co; total dose of 4.5 Mrad) at the ␥-irradiation facility of the Breazeale nuclear reactor at Pennsylvania State University. During irradiation, samples were maintained at 77 K by immersion in liquid N 2 . Alkaline myoglobin was prepared by dissolving horse heart myoglobin (Sigma, St. Louis, MO) in 50 mM borate buffer (pH͞pD 10.4͞10.9, where pD ϭ Ϫlog[D 3 O ϩ ]). Continuous-wave Xband EPR and ENDOR measurements were performed on an Elexsys E-560 (Bruker, Billerica, MA) equipped with a liquid helium cryostat (Oxford Instruments, Oxon, U.K.) and a 150-W radiofrequency (rf) amplifier (see Fig. 4 and also Fig.  6 , which is published as supporting information on the PNAS web site). Typical experimental conditions were as follows: sample temperature, 10 K; microwave frequency, 9.43 GHz; † Protein obtained from the growth of C. fumago on minimal medium ( 57 Fe-enriched protein) appeared to have less background fluorescence. Fig. 3 . Cryoreduction of CPO-II. A sample of CPO-II containing 20% glycerol was ␥-irradiated at 77 K, resulting in reduction of the EPR-silent Fe(IV)OH center. The Fe(III)OH species generated by this process is EPR active, and ENDOR measurements revealed a very strongly coupled (13.4 MHz) exchangeable proton. microwave power, 40 mW; rf modulation, 20 kHz; rf modulation depth of the rf field, 100 kHz; rf attenuation, 0 dB.
